87 results on '"DiPiazza A"'
Search Results
2. Supplemental Table 5 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
3. Supplemental Table 2 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
4. Supplementary Figures from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
5. Supplemental Table 2 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
6. Supplemental Table 5 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
7. Supplemental Table 4 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
8. Supplementary Data from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
9. Supplemental Table 3 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
10. Supplemental Table 3 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
11. Supplementary Figures from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
12. Supplemental Table 4 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
13. Supplementary Data from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
14. Supplemental Table 6 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
15. Supplemental Table 1 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
16. Supplemental Table 1 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
17. Supplemental Table 6 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
18. Data from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
19. A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
20. Histone H3 tail modifications alter structure and dynamics of the H1 C-terminal domain within nucleosomes
21. Histone H3 tail modifications regulate structure and dynamics of the H1 C-terminal domain within nucleosomes
22. Associations between plant-based diets, plant foods and botanical supplements with gestational diabetes mellitus: a systematic review protocol
23. Analyses of Cellular Immune Responses in Ferrets Following Influenza Virus Infection
24. Smoking Addiction in Patients with Schizophrenia Spectrum Disorders and Its Perception and Intervention in Healthcare Personnel Assigned to Psycho-Rehabilitation Programs: A Qualitative Research
25. Altering the mRNA-1273 dosing interval impacts the kinetics, quality, and magnitude of immune responses in mice
26. A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline glioma
27. Genetic dissection of nitrogen induced changes in the shoot and root biomass of spinach
28. Feasibility of a Web-Based Intervention to Prevent Perinatal Depression and Promote Human Milk Feeding: Randomized Pilot Trial
29. Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine
30. A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline glioma
31. Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants
32. COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge
33. Feasibility of a Web-Based Intervention to Prevent Perinatal Depression and Promote Human Milk Feeding: Randomized Pilot Trial (Preprint)
34. Spreading and epigenetic inheritance of heterochromatin require a critical density of histone H3 lysine 9 tri-methylation
35. Selection of nitrogen responsive root architectural traits in spinach using machine learning and genetic correlations
36. A Single-Arm, Open-Label, Pilot, and Feasibility Study of a High Nicotine Strength E-Cigarette Intervention for Smoking Cessation or Reduction for People With Schizophrenia Spectrum Disorders Who Smoke Cigarettes
37. Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants
38. T cell immunity to SARS-CoV-2 following natural infection and vaccination
39. Sensory experiences and cues among E-cigarette users
40. Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes
41. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
42. Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes
43. SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness
44. Treatment of Acute Delirium in a Patient with Parkinson’s Disease by Transfer to the Intensive Care Unit and Administration of Dexmedetomidine
45. Functional Relevance of Citrulline in the Vegetative Tissues of Watermelon During Abiotic Stresses
46. Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes
47. P2.01-18 ORION: Durvalumab+Olaparib Versus Durvalumab Alone as Maintenance Therapy in Stage IV Non-Small Cell Lung Cancer (NSCLC)
48. A Novel Vaccine Strategy to Overcome Poor Immunogenicity of Avian Influenza Vaccines through Mobilization of Memory CD4 T Cells Established by Seasonal Influenza
49. OMIP‐061: 20‐Color Flow Cytometry Panel for High‐Dimensional Characterization of Murine Antigen‐Presenting Cells
50. ORION: A Phase 2, randomized, multicenter, double-blind study to assess efficacy and safety of durvalumab+olaparib vs durvalumab alone as maintenance therapy in Stage IV non-small cell lung cancer (NSCLC).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.